FCPS Part 1 PhysiologyGynae & Obs Paper 2

Mechanism of hormone action

Mechanism of hormone action: receptors, second messengers and receptor disorders

How hormones act, for FCPS Part 1: surface receptors using cAMP, IP3 and DAG, cGMP, tyrosine kinase and JAK–STAT, and intracellular steroid receptors. Links each messenger to obstetric drugs, ovulation induction, antenatal steroids and receptor diseases.

Two families of hormone

FeaturePeptides, glycoproteins, catecholaminesSteroids, thyroid hormone, vitamin D
StorageSecretory granules; released by exocytosisNot stored: made on demand and diffuse out as made
TransportMostly unbound in plasma; short half-lifeOn binding proteins (SHBG, CBG, TBG); longer half-life
ReceptorCell surfaceIntracellular (cytoplasm or nucleus)
SpeedSeconds to minutesHours (transcription and protein synthesis)
  • Steroid-making cells such as the corpus luteum take most of their cholesterol from plasma LDL by receptor-mediated endocytosis through the LDL receptor.
  • hCG lasts much longer than LH, though both bind the same LH/hCG receptor, because its beta subunit carries a carboxy-terminal extension rich in sialic acid; sialylated sugars delay hepatic clearance. One injection acts for days (the IVF trigger), which also raises the risk of ovarian hyperstimulation.

G protein-coupled receptors (seven transmembrane)

  • The receptor makes the alpha subunit swap GDP for GTP; the active alpha subunit acts on its enzyme until its own GTPase hydrolyses GTP back to GDP, which switches it off.
G proteinEnzyme and messengerExamples
GsActivates adenylate cyclase, raises cAMPFSH, LH, hCG, TSH, ACTH, PTH, glucagon, ADH (V2), beta-adrenergic, calcitonin, H2
GiInhibits adenylate cyclase, lowers cAMPD2 (dopamine on lactotrophs), alpha-2, M2, opioid, somatostatin
GqActivates phospholipase C: PIP2 splits into IP3 and DAGGnRH, TRH, oxytocin, ADH (V1), alpha-1, angiotensin II, PGF2-alpha, M1 and M3
  • cAMP acts through protein kinase A. cAMP binds the regulatory subunits of PKA (two regulatory, two catalytic), freeing the catalytic subunits to phosphorylate enzymes within minutes.
  • cAMP also acts slowly on genes: PKA phosphorylates CREB (cAMP response element-binding protein), which switches on genes such as aromatase in granulosa cells within hours of FSH. Phosphodiesterase degrades cAMP and ends the signal.
  • Each step activates many molecules, so tiny hormone concentrations give large responses (amplification).
  • Gq pathway: IP3 opens the IP3 receptor calcium channel on the endoplasmic (sarcoplasmic) reticulum; DAG with calcium activates protein kinase C.
  • ADH: V2 receptors (Gs, cAMP) in the collecting duct cause PKA to insert aquaporin-2 channels into the luminal membrane; V1 receptors (Gq) on vessels cause vasoconstriction.

Myometrium as a worked example

AgentReceptor and messengerUterine effect
Oxytocin, PGF2-alphaGq, IP3 raises calciumContraction
Phenylephrine and other alpha-1 agonistsAlpha-1, GqContraction
Beta-2 agonists (salbutamol, terbutaline)Gs, cAMP; PKA inhibits myosin light-chain kinaseRelaxation
Glyceryl trinitrateNO, cGMPBrief relaxation
NifedipineL-type calcium channel block (no receptor)Relaxation
  • Calcium binds calmodulin, which activates myosin light-chain kinase: contraction. Adrenaline acts on both alpha-1 and beta-2, so its effect depends on dose.

Errors in G protein signalling

ConditionDefect
Cholera toxinADP-ribosylates Gs-alpha, keeping it on
Pertussis toxinADP-ribosylates Gi, preventing its activation
McCune–Albright syndromeActivating Gs-alpha mutation that abolishes GTP hydrolysis: ovaries secrete oestrogen without FSH or LH (peripheral precocious puberty), café-au-lait spots, fibrous dysplasia
PseudohypoparathyroidismInactivating Gs-alpha mutation: no cAMP rise to PTH
  • Desensitisation: prolonged agonist exposure uncouples and internalises receptors. After many hours of oxytocin augmentation the uterus responds poorly, risking atonic PPH.
  • GnRH must be pulsatile (every 60–90 minutes) to keep pituitary receptors responsive. A pump giving pulses induces ovulation in hypothalamic amenorrhoea; it cannot work if the pituitary is destroyed (Sheehan syndrome). Continuous agonist first causes a flare, then down-regulation. GnRH antagonists block without a flare.

Cyclic GMP

  • Membrane guanylyl cyclase: ANP and BNP.
  • Soluble guanylyl cyclase: nitric oxide. cGMP activates protein kinase G, which relaxes smooth muscle. Penile and clitoral erection uses parasympathetic NO and cGMP; PDE5 inhibitors prolong it.

Enzyme-linked receptors

  • Receptor tyrosine kinase: insulin, IGF-1, growth factors. Autophosphorylation then IRS, PI3K and Akt, moving GLUT4 to the membrane. In gestational diabetes placental hormones blunt post-receptor steps; chronic hyperinsulinaemia down-regulates receptors.
  • Cytokine receptors with JAK–STAT: GH, prolactin, erythropoietin, leptin (low leptin in very lean athletes suppresses GnRH).

Intracellular receptors

  • Structure: ligand-binding domain, DNA-binding domain (zinc fingers), transactivation domain. Cortisol is the classic hormone whose receptor binds DNA directly at hormone response elements. Thyroid hormone is an amine but behaves like a steroid.
  • Glucocorticoid receptor waits in the cytoplasm bound to heat shock protein 90; hormone releases it and the complex enters the nucleus. Oestrogen receptor is mainly nuclear.
  • Thyroid hormone and vitamin D receptors sit on DNA as heterodimers with the retinoid X receptor. Calcitriol raises duodenal calcium absorption by inducing calbindin, so the effect takes days.
  • Antenatal betamethasone works best after about 24 hours because new transcription is needed: alveolar type II pneumocytes increase surfactant.
  • Tissue-selective modulators: the same receptor recruits different co-activators and co-repressors in each tissue. Tamoxifen is an antagonist in breast but an agonist in endometrium; raloxifene does not stimulate the endometrium; fulvestrant causes receptor degradation.

Receptor disorders

DisorderReceptor problem
Complete androgen insensitivityAndrogen receptor mutation; gene on the X chromosome, so X-linked, passed through carrier mothers; testosterone normal or high
Familial hypercholesterolaemiaLDL receptor deficiency: very high LDL, tendon xanthomas, early MI
Nephrogenic diabetes insipidusV2 receptor or aquaporin-2 defect
Myasthenia gravisAntibodies block and destroy postsynaptic nicotinic ACh receptors: fatigable ptosis and diplopia
Graves diseaseAntibodies stimulate the TSH receptor
Type 2 diabetes, PCOSPost-receptor insulin resistance and receptor down-regulation

Obstetric drugs and their receptors

DrugReceptor and effect
OxytocinOxytocin receptor (Gq); at high doses acts on V2: water retention, hyponatraemia
AtosibanBlocks oxytocin and vasopressin V1a receptors
ErgometrineAlpha-adrenergic and 5-HT2: uterine contraction and hypertension
CarboprostFP receptor on uterus and bronchi: bronchospasm in asthma
Dicyclomine, oxybutyninBlock muscarinic M3: relax gut and bladder smooth muscle
  • Some drugs act without any receptor: antacids, osmotic diuretics (mannitol), chelating agents and bulk laxatives work by chemical or physical properties.

Remember Peptides are stored and act at the surface; steroids are made on demand and act in the nucleus.

Exam trap FSH and LH use cAMP; GnRH and oxytocin use IP3 and DAG. Do not mix the two levels of the axis.

Exam trap Insulin, GH and prolactin do not use cAMP: insulin uses a tyrosine kinase, GH and prolactin use JAK–STAT.

How FCPS asks about this

  • cAMP acts through: protein kinase A; on genes via phosphorylated CREB.
  • Phospholipase C is the messenger route of: GnRH, oxytocin, TRH, alpha-1 and V1 receptors.
  • cGMP is the second messenger of: nitric oxide and ANP.
  • Hormone acting through an intracellular receptor that binds DNA: cortisol (also other steroids, thyroid hormone, vitamin D).
  • Why GnRH is given in pulses: pulses keep pituitary GnRH receptors responsive; continuous exposure down-regulates them.
  • Why hCG lasts longer than LH: high sialic acid content of its beta-subunit tail.
  • McCune–Albright defect: Gs-alpha that cannot hydrolyse GTP.

Test yourself on this topic

5 of the 94 questions in our bank on this topic. Choose an answer to see why every option is right or wrong.

Question 1Medium

Antenatal betamethasone reduces respiratory distress in preterm babies. Through glucocorticoid receptor–driven gene transcription, which fetal lung cells increase surfactant production?

Question 2Hard

A woman with bipolar disorder planning pregnancy asks how lithium works. One proposed mechanism is that it damps signalling through Gq-coupled receptors by limiting recycling of PIP2. Which enzyme does lithium inhibit?

Question 3Medium

LH acting on theca cells raises cAMP, which activates protein kinase A. How does cAMP activate this enzyme?

Question 4Medium

A woman in preterm labour is given a β2-agonist infusion, and her contractions weaken. The drug raises cAMP in myometrial cells. Which action of protein kinase A then relaxes the muscle?

Question 5Medium

A woman with hypothyroidism has raised prolactin because hypothalamic releasing hormone excess stimulates lactotrophs. Which of the following hormones acts mainly through a Gq-coupled receptor and IP3?

Practise all 94 questions on this topic

Where this sits in the CPSP syllabus

  • Obstetrics & Gynaecology, Paper 2: Endocrinology, Mechanism of hormone action; receptors and second messengers

Read next

Drug dose pages

Doses, cautions and practical tips for drugs in this chapter.